necitumumab in nsclc
Published 9 years ago • 463 plays • Length 4:35Download video MP4
Download video MP3
Similar videos
-
1:48
dr. fred hirsch on next steps for necitumumab in nsclc
-
2:05
necitumumab in squamous nsclc
-
2:25
dr. paz-ares on connection of egfr-expression and necitumumab response in nsclc
-
1:29
dr. besse on combination of necitumumab and abemaciclib in nsclc
-
3:35
potential new biomarkers in lung cancer
-
10:54
new therapies for squamous nsclc
-
2:27
necitumumab effective antibody against egfr for squamous lung cancer patients?
-
1:15
phase iii squire trial in patients with nsclc treated with necitumumab
-
6:31
appropriate settings for the pacific regimen in nsclc
-
1:05
dr. ramalingam on the activity of osimertinib combinations in nsclc
-
7:07
mutation testing in nsclc
-
1:33
dr. giaccone on treatment options in nsclc
-
0:39
dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc
-
1:38
necitumumab plus pembrolizumab: a viable alternative for nsclc
-
6:43
molecular testing in patients with metastatic nsclc
-
1:18
dr. natale on the evolution of immunotherapy in nsclc
-
7:01
actual use of pembrolizumab and chemotherapy in nsclc
-
1:17
dr. chaft on investigational neoadjuvant immunotherapy approaches in nsclc
-
1:00
dr. kris on the impact of bevacizumab biosimilars in lung cancer